Leerink Swann maintains an 'Outperform' on Corcept Therapeutics (CORT); Korlym Approved. Launch To Start On May 1

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/13/2026

1. SKHY
2. USO
3. SPY
4. META
5. PEP
6. DAL
7. SKHYV
8. ALP
9. NVDA
10. NRIX

Go back to Leerink Swann maintains an 'Outperform' on Corcept Therapeutics (CORT); Korlym Approved. Launch To Start On May 1